Michael T. Andriole - Aug 1, 2023 Form 4 Insider Report for CHIMERIX INC (CMRX)

Role
President and CEO, Director
Signature
/s/ Michael Alrutz, Attorney-in-Fact
Stock symbol
CMRX
Transactions as of
Aug 1, 2023
Transactions value $
$29,750
Form type
4
Date filed
8/1/2023, 05:32 PM
Previous filing
May 19, 2023
Next filing
Dec 29, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CMRX Common Stock Award $29.8K +25K +7% $1.19 382K Aug 1, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CMRX Stock Option (Right to Buy) Award $0 +150K $0.00 150K Aug 1, 2023 Common Stock 150K $1.19 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares being reported are being issued pursuant to restricted stock unit awards ("RSUs"), each one of which represents a contingent right to receive one share of the Issuer's common stock. The shares subject to the RSUs will vest in equal annual installments over a four year period from 08/01/2023, so long as the Reporting Person continues to provide services to the Issuer.
F2 The shares subject to the nonstatutory stock option ("Option"), under Chimerix, Inc.'s 2013 Equity Incentive Plan, will vest over a period of four years so long as the Reporting Person continues to provide services to the Issuer, with 25% of the shares subject to the Option vesting on 08/01/2024 and the balance of shares vesting in 36 equal monthly installments over the remaining three years.